Barth, B. M., Wang, W., Toran, P. T., Fox, T. E., Annageldiyev, C., Ondrasik, R. M., . . . Claxton, D. F. (2019). Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia. Blood Adv.
Citación estilo ChicagoBarth, Brian M., et al. "Sphingolipid Metabolism Determines the Therapeutic Efficacy of Nanoliposomal Ceramide in Acute Myeloid Leukemia." Blood Adv 2019.
Cita MLABarth, Brian M., et al. "Sphingolipid Metabolism Determines the Therapeutic Efficacy of Nanoliposomal Ceramide in Acute Myeloid Leukemia." Blood Adv 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.